Both in Biotechnology
4D Molecular Therapeutics vs Ginkgo Bioworks Holdings
Over the past year FDMT returned +73.5% and DNA returned −9.6%; their daily moves had a correlation of 0.29.
FDMT +73.5% DNA −9.6%Growth of $1, one year, split-adjusted
| Metric | FDMT | DNA |
|---|---|---|
| Price | $14.49 | $11.96 |
| Market cap | $800.5M | $805.4M |
| Today | −0.48% | +14.34% |
| 1 month | −1.2% | +71.8% |
| 6 months | +69.1% | +118.2% |
| Year to date | +93.2% | +43.9% |
| 1 year | +72.7% | +4.0% |
| Revenue growth (YoY) | +25106.7% | −48.5% |
| Gross margin | 100.0% | 91.5% |
| Net margin | −1929.0% | −231.7% |
| P/E (TTM) | — | — |
| Price / sales | 8.7× | 7.2× |
| Net cash | $341.7M | $302.2M |
| Dividend yield | — | — |
| Volatility (60d) | 68.4% | 100.6% |
| Short % of float | 27.0% | 16.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).